glp-1 shortages After Novo and Lilly resolved shortages, where does the compounding industry stand? Experts weigh in Navigating the Weight-Loss Drug Market:

The report tracks competitive developments, strategies, mergers and acquisitions and new product development

Benefit of Delayed Fertility Therapy with Preconception Weight Loss over Immediate Therapy in Obese Women with PCOS. The Journal of Clinical Endocrinology & Metabolism , vol

Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study , (December 18, 2023)

However, the long-term cardiovascular and renal benefits need to be carefully evaluated against the risk of DKA

Weekly body weight measurements confirmed that the low dose of semaglutide (30 nmol/kg biweekly) did not alter body weight over the 16-week treatment period Figure 1B and semaglutide treated rats continued to gain weight during the 16 week experimental protocol